Your browser doesn't support javascript.
loading
Blocking LAIR1 signaling in immune cells inhibits tumor development.
Xie, Jingjing; Gui, Xun; Deng, Mi; Chen, Heyu; Chen, Yuanzhi; Liu, Xiaoye; Ku, Zhiqiang; Tan, Lingxiao; Huang, Ryan; He, Yubo; Zhang, Bruce; Lewis, Cheryl; Chen, Kenian; Xu, Lin; Xu, Jian; Huang, Tao; Liao, X Charlene; Zhang, Ningyan; An, Zhiqiang; Zhang, Cheng Cheng.
Affiliation
  • Xie J; Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Gui X; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX, United States.
  • Deng M; Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Chen H; Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Chen Y; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX, United States.
  • Liu X; Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Ku Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX, United States.
  • Tan L; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX, United States.
  • Huang R; Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • He Y; Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Zhang B; Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Lewis C; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Chen K; Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Xu L; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Xu J; Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Huang T; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Liao XC; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Zhang N; Immune-Onc Therapeutics, Inc, Palo Alto, CA, United States.
  • An Z; Immune-Onc Therapeutics, Inc, Palo Alto, CA, United States.
  • Zhang CC; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX, United States.
Front Immunol ; 13: 996026, 2022.
Article in En | MEDLINE | ID: mdl-36211388
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immune Checkpoint Inhibitors / Neoplasms Limits: Animals / Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immune Checkpoint Inhibitors / Neoplasms Limits: Animals / Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: Country of publication: